Can I throw a question out?
If they are talking about phase 2 trials then wouldn't this trial to be approved need data from the DF trial establishing the MTD. (I am stating that as what I believe as fact)
So the DF trial MUST be progressing with data that will be worthwhile of pursuit of a phase 2 trial status at Beth Israel from the FDA and data that will support the grant application process for funds to support that trial.
I think we have a winner here!!!
Oh and I miss everyone!